Your browser doesn't support javascript.
loading
Prothrombotic markers in NIDDM
Mansoura Medical Journal. 1994; 24 (3-4): 177-183
em En | IMEMR | ID: emr-108123
Biblioteca responsável: EMRO
The present work comprised the study of 50 cases besides 10 controls. The necessary clinical and laboratory investigations had been carried out for all subjects. In addition, PC was assayed. A significant prolongation of PT, APTT has been observed in all diabetic group as compared to the control group. Insignificant decrease in fibrinogen level has been observed in all diabetic group as compared to control group. Insignificant increase in PC activity has been observed in all diabetic group as compared to control group. This may be an attempt by the body to overcome hypercoagulability [Vigano et al. 1984]. Significant decrease in PC activity has been observed in diabetic bilharzial group as compared to the diabetic non bilharzial group
Assuntos
Buscar no Google
Índice: IMEMR Assunto principal: Fibrinogênio / Fibrina / Biomarcadores Idioma: En Revista: Mansoura Med. J. Ano de publicação: 1994
Buscar no Google
Índice: IMEMR Assunto principal: Fibrinogênio / Fibrina / Biomarcadores Idioma: En Revista: Mansoura Med. J. Ano de publicação: 1994